Summary by Moomoo AI
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on April 1, 2024. The transaction involved a grant of 1,467 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 56,314 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.